` Comparison: STTK, CYTH - Alpha Spread

STTK
vs
CYTH

Over the past 12 months, STTK has significantly outperformed CYTH, delivering a return of +186% compared to the CYTH's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
STTK
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

STTK Intrinsic Value
HIDDEN
Show
CYTH Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Shattuck Labs Inc
NASDAQ:STTK
3.15 USD
Cyclo Therapeutics Inc
NASDAQ:CYTH
9 900 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
STTK, CYTH

STTK
CYTH
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Shattuck Labs Inc
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
STTK, CYTH

STTK
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Shattuck Labs Inc
NASDAQ:STTK
Cyclo Therapeutics Inc
NASDAQ:CYTH
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

STTK
0%
CYTH
91.3%

Operating Margin

STTK
-5 813.7%
CYTH
-2 834.1%

Net Margin

STTK
-5 521.6%
CYTH
-2 848.3%

FCF Margin

STTK
-4 946.3%
CYTH
-2 586.2%

ROE

STTK
-58.1%
CYTH
341.5%

ROA

STTK
-52%
CYTH
-457.1%

ROIC

STTK
-362.8%
CYTH
1 154.9%

ROCE

STTK
-59.6%
CYTH
340.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
STTK, CYTH

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
STTK, CYTH

Performance Gap Between STTK and CYTH
HIDDEN
Show

Performance By Year
STTK, CYTH

Loading
STTK
CYTH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare STTK to other stocks
Unlock Full Access to Alpha Spread
Create Free Account